Table 1.
Characteristics of patients investigated in this study
| Non-inflammatory controls* (n = 31) | Inflammatory controls† (n = 15) | CD (n = 26) | UC (n = 31) | |
| Mean age (y) | 52 (26–74) | 50 (20–82) | 35 (16–56) | 44 (23–74) |
| Sex (M/F) | 10/21 | 6/9 | 9/17 | 18/13 |
| Localisation | ||||
| Right colon | 29 | 6 | 15 | 9 |
| Left colon | 2 | 9 | 11 | 22 |
| Treatment | ||||
| Corticosteroids | 0 | 0 | 9 | 8 |
| Purine analogues | 0 | 0 | 2 | 1 |
| 5-ASA | 0 | 0 | 2 | 16 |
| Specific disease activity | – | – | CDAI >150 | CAI >4 |
*Patients without suspicious macroscopic or histological findings (n = 20), patients with diverticulosis (n = 7), and patients with polyps (n = 4).
†Patients with undetermined colitis (n = 2), unclear diarrhoea (n = 5), infectious diarrhoea (n = 7), and patients with radiation colitis (n = 1).
5-ASA, 5-aminosalicyclic acid.